Latest news
TNX-103 misses primary endpoint in phase 3 LEVEL PH-HFpEF trial - HCPLiveHCPLive · Mon, 10 Aug 2026 14:36:46 GMT#PTVNewsTonight | 4 fast-response cutters part of U.S. rotational deployment in PH to serve as PCG partners in West Philippine Sea patrolling - facebook.comfacebook.com · Mon, 10 Aug 2026 14:33:56 GMTAI can power PH growth but threatens BPO: World Bank - Outsource AcceleratorOutsource Accelerator · Mon, 10 Aug 2026 13:48:20 GMTPH could lose Pax Silica if it ‘drops the ball’ — Ambassador Romualdez - ABS-CBNABS-CBN · Mon, 10 Aug 2026 13:38:47 GMTTenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF - investingnews.cominvestingnews.com · Mon, 10 Aug 2026 12:54:11 GMTEikon Therapeutics Appoints Johnny Bennett, Ph.D. to its Scientific Advisory Board - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:40:26 GMTOrion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) did not reach its primary endpoint - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:58 GMTInside Mitsubishi’s long-term P7-B bet on PH-made hybrid vehicles - RapplerRappler · Mon, 10 Aug 2026 11:14:30 GMT